1000+ Policymakers and Dozens of Global Academic Leaders Outline the Trillion-Dollar Precision Medicine Market

Since President Obama first introduced the concept of “Precision Medicine” in his State of the Union address in 2015, the development of precision medicine has spread rapidly across the globe, with countries eagerly pursuing related concepts and industries. China is no exception. In 2016, China’s precision medicine sector entered an acceleration phase. On March 5, the National Development and Reform Commission (NDRC) released the Outline of the 13th Five-Year Plan, which included 100 major projects. Among them, “accelerating the large-scale application of biotechnologies such as genomics” was prominently featured, signaling that genomics had been elevated to a national strategic priority.

Standardization and strong support at the national policy level, combined with continuous technological innovation and development, have propelled precision medicine in China onto a fast track of growth. As the industrialization of precision medicine continues to advance, it is poised to evolve into a trillion-yuan market. In the era of big data, stakeholders stand to reap substantial dividends from these technological advancements, seize new development opportunities amidst the wave of contemporary reforms, and explore new research directions. The 2nd Global Precision Medicine (China) Summit 2017 will be grandly held at the Everbright International Hotel & Convention Center in Shanghai from December 1–3, 2017. The event is jointly organized by Shanghai Wanyi Exhibition Management Co., Ltd. and the Chinese-American Pharmaceutical Association (CAPA), with co-organization support from the Shanghai Bio-medicine Industry Association and the Shanghai Pudong New Area Bio-industry Association.

This year’s event stands as the largest, most prestigious, geographically broadest, and most influential gathering for academic, industrial, investment, and international peer exchanges in China’s precision medicine sector. Previously, the 2016 Global Precision Medicine (China) Summit had already garnered high acclaim from stakeholders across all sectors.

Guest List Continuously Updated

The conference will bring together over 1,000 attendees, including policymakers from government regulatory agencies, academicians, professors, scholars, and leading scientific and technological experts in the field of precision medicine from China and abroad, directors of renowned oncology hospitals and clinicians, representatives from innovative pharmaceutical companies, life sciences and biotechnology firms, CROs, big data solution providers, and senior executives from investment institutions specializing in precision medicine. Over the course of three days, participants will convene to discuss global trends in precision medicine and envision its future landscape.

The conference features a distinguished expert team led by prominent figures from government agencies and industry associations, including Huang Jing, Director of the China National Center for Biotechnology Development; Xiu Qingyu, Clinical Data Verification Expert at the China Food and Drug Administration (CFDA); Dr. Sir John Burn, Non-Executive Director of the UK National Health Service (NHS); Dr. Leigh Verbois, Director of the U.S. Food and Drug Administration (FDA) China Office; David F. Stroncek, Director of the Cell Therapy Medicine and Cell Preparation Center at the U.S. National Institutes of Health (NIH); Jonathan Sprent, Former President of the American Association of Immunologists; Gao Dayong, President of the Society for Cryobiology; Edward Abrahams, President of the Personalized Medicine Coalition (PMC); and Massimo Dominici, Former President of the International Society for Cellular Therapy. This esteemed lineup sets a high-profile tone for the event.

In addition, there are 32 top global academic experts from research institutions and medical organizations, including seven academicians, as well as senior representatives from precision medicine companies and investment firms both in China and abroad.

2017 2nd Global Precision Medicine (China）SummitIn keeping with the style of the Global Precision Medicine (China) Summit over the past 16 years, in addition to mainland China, our invited attendees will come fromChina's Hong Kong and Taiwan Regions, the United States, Europe, Japan, South Korea, and Singaporeand other countries and regions, where nearly a thousand international experts engaged in vibrant intellectual exchange.

Themed “Harnessing Innovative Forces, Gaining Insights into the Frontiers of Development,” this forum brings together diverse perspectives to foster dialogue on hot topics such as global trends in precision medicine and cutting-edge innovative technologies. Here, you will gain access to the most advanced professional expertise, identify the most suitable partners, and connect with the most specialized customer base. Through a rich array of conference formats and content meticulously arranged by the Organizing Committee—including keynote speeches, expert brainstorming sessions, product exhibitions, and interactive customer experiences—we provide you with the latest technical insights, convey industry development trends and emerging dynamics, and offer extensive opportunities for international exchange and cooperation. Engage closely with leading authorities, heed the insights of renowned experts, and jointly explore the future prospects and outlook for the precision medicine industry.

Precision medicine, inherently endowed with the genes of an emerging industry, will usher in a renaissance for numerous associated industries as it enters a phase of rapid advancement. Although precision medicine is driving fundamental transformations in the healthcare sector and may even spur the development of new industries, it still faces many difficulties and challenges; thus, there is a long road ahead. The future lies before us, waiting for us to rise to the occasion, keep pace with the times, seize both challenges and opportunities, unleash our imagination in the field of precision medicine, look forward to its promising prospects, and map out the grand vision of a trillion-dollar market in this domain!

Become an official VCBeat member to enjoy priority free access to more high-quality offline events!And, in the coming year, you will have unlimited access to the completeIndustry Trends Report, promptly grasp the latest globalInvestment and Financing Information, boasting comprehensive medicalEnterprise Database, and a vast amount ofResource Matching。

Scan the QR code to become a VCBeat member,

Beta Version Trial Price: CNY 365/year.

2017 2nd Global Precision Medicine (China）Summit Tickets Are Now on Hot Pre-Sale.At this conference, VCBeat, as a media partner, has prepared exclusive benefits for our new VCBeat members! Anyone who becomes a member between July 1 and July 5VCBeat Memberusers of, through “Exclusive Access for New Elite Members”, you will have the opportunity to receive a complimentary conference ticket valued at 1,800 yuan.

Exclusive Channel for New Elite Members

Long-press to scan the QR code and apply now.